This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Effects of Clonidine in Depressed Patients and Healthy Subjects

Dennis S. Charney, MD; George R. Heninger, MD; David E. Sternberg, MD; Karen M. Hafstad, RN; Suzanne Giddings; D. Harold Landis

Arch Gen Psychiatry. 1982;39(3):290-294.

Abstract
• Several recent investigations have raised the possibility that the sensitivity of ₂-adrenergic receptor may be of etiologic importance in depression. To assess whether abnormalities in the presynaptic ₂-adrenergic receptor exist in depressed patients not taking drugs, the effects of an ₂ agonist, clonidine, on plasma 3-methoxy-4-hydroxyphenelethyleneglycol (MHPG) and on blood pressure (BP) were evaluated in 15 depressed patients and 12 healthy controls of similar age. The ability of clonidine to increase growth hormone (GH) secretion was also assessed. The effect of clonidine on plasma MHPG and BP was not different between the depressed patients and controls. However, the GH response to clonidine was blunted in the depressed patients. These results suggest that in depression (1) the sensitivity of the presynaptic ₂-adrenergic receptor is not abnormal, and (2) the sensitivity of postsynaptic adrenergic receptors may be decreased.

Author Affiliations
From the Department of Psychiatry, Yale University School of Medicine, and the Connecticut Mental Health Center, New Haven.

Footnotes
Accepted for publication Oct 27, 1981.

Reprint requests to Connecticut Mental Health Center, 34 Park St, New Haven, CT 06508 (Dr Charney).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Coronary Artery Disease and Depression: Patients With More Depressive Symptoms Have Lower Cardiovascular Reactivity During Laboratory-Induced Mental Stress
York et al.
Psychosom. Med. 2007;69:521-528.
ABSTRACT | FULL TEXT  

The Role of Norepinephrine in the Behavioral and Psychological Symptoms of Dementia
Herrmann et al.
J. Neuropsychiatry Clin. Neurosi. 2004;16:261-276.
ABSTRACT | FULL TEXT  

Regional Brain Metabolic Correlates of {alpha}-Methylparatyrosine-Induced Depressive Symptoms: Implications for the Neural Circuitry of Depression
Bremner et al.
JAMA 2003;289:3125-3134.
ABSTRACT | FULL TEXT  

PSYCHOPATHOLOGY IN ALCOHOL WITHDRAWAL: RELATIONSHIP TO {alpha}2-ADRENOCEPTOR FUNCTION
Fahlke et al.
Alcohol Alcohol 1999;34:750-759.
ABSTRACT | FULL TEXT  

Regulation of Signal Transduction Pathways and Gene Expression by Mood Stabilizers and Antidepressants
Chen et al.
Psychosom. Med. 1999;61:599-617.
ABSTRACT | FULL TEXT  

Platelet {alpha}2-adrenoreceptors in depression: a critical examination
Grossman et al.
J Psychopharmacol 1993;7:4-18.
ABSTRACT  

Reduced Clonidine Rapid Eye Movement Sleep Suppression in Patients With Primary Major Affective Illness
Schittecatte et al.
Arch Gen Psychiatry 1992;49:637-642.
ABSTRACT  

Blunted Growth Hormone Response to Clonidine in Patients With Generalized Anxiety Disorder
Abelson et al.
Arch Gen Psychiatry 1991;48:157-162.
ABSTRACT  

Behavioral and Physiologic Effects of Short-term and Long-term Administration of Clonidine in Panic Disorder
Uhde et al.
Arch Gen Psychiatry 1989;46:170-177.
ABSTRACT  

{alpha}2-Adrenergic Receptor Sensitivity in Depression: The Plasma MHPG, Behavioral, and Cardiovascular Responses to Yohimbine
Heninger et al.
Arch Gen Psychiatry 1988;45:718-726.
ABSTRACT  

Clonidine challenge testing of alpha-2-adrenoceptor function in man: the effects of mental illness and psychotropic medication
Glue et al.
J Psychopharmacol 1988;2:119-137.
ABSTRACT  

The Effects of Dieting and Weight Loss on Neuroendocrine Responses to Tryptophan, Clonidine, and Apomorphine in Volunteers: Important Implications for Neuroendocrine Investigations in Depression
Goodwin et al.
Arch Gen Psychiatry 1987;44:952-957.
ABSTRACT  

Situational Panic Attacks: Behavioral, Physiologic, and Biochemical Characterization
Woods et al.
Arch Gen Psychiatry 1987;44:365-375.
ABSTRACT  

Abnormal Regulation of Noradrenergic Function in Panic Disorders: Effects of Clonidine in Healthy Subjects and Patients With Agoraphobia and Panic Disorder
Charney and Heninger
Arch Gen Psychiatry 1986;43:1042-1054.
ABSTRACT  

Serotonin Function in Panic Disorders: The Effect of Intravenous Tryptophan in Healthy Subjects and Patients With Panic Disorder Before and During Alprazolam Treatment
Charney and Heninger
Arch Gen Psychiatry 1986;43:1059-1065.
ABSTRACT  

{alpha}2-Adrenergic Receptor Function in Depression: The Cortisol Response to Yohimbine
Price et al.
Arch Gen Psychiatry 1986;43:849-858.
ABSTRACT  

Biochemical and Functional Evidence of Supersensitive Platelet {alpha}2-Adrenoceptors in Major Affective Disorder: Effect of Long-term Lithium Carbonate Treatment
Garcia-Sevilla et al.
Arch Gen Psychiatry 1986;43:51-57.
ABSTRACT  

Exaggerated Orthostatic Responsivity of Plasma Norepinephrine in Depression
Rudorfer et al.
Arch Gen Psychiatry 1985;42:1186-1192.
ABSTRACT  

Noradrenergic Function and the Mechanism of Action of Antianxiety Treatment: II. The Effect of Long-term Imipramine Treatment
Charney and Heninger
Arch Gen Psychiatry 1985;42:473-481.
ABSTRACT  

Platelet {alpha}2-Adrenergic Receptor Binding and Plasma Catecholamines: Before and During Imipramine Treatment in Patients With Panic Anxiety
Cameron et al.
Arch Gen Psychiatry 1984;41:1144-1148.
ABSTRACT